ARMISTICE CAPITAL, LLC - BRIACELL THERAPEUTICS CORP ownership

BRIACELL THERAPEUTICS CORP's ticker is BCTXW and the CUSIP is 10778Y112. A total of 5 filers reported holding BRIACELL THERAPEUTICS CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ARMISTICE CAPITAL, LLC ownership history of BRIACELL THERAPEUTICS CORP
ValueSharesWeighting
Q3 2023$926,250
-1.2%
375,0000.0%0.01%0.0%
Q2 2023$937,500
-15.5%
375,000
-0.0%
0.01%
-12.5%
Q1 2023$1,110,000
+43.7%
375,001
+0.0%
0.02%
+23.1%
Q4 2022$772,463
-28.2%
375,0000.0%0.01%
-31.6%
Q3 2022$1,076,000
+10.4%
375,0000.0%0.02%
+11.8%
Q2 2022$975,000
-50.0%
375,0000.0%0.02%
-55.3%
Q1 2022$1,950,000
+10.9%
375,0000.0%0.04%
+31.0%
Q4 2021$1,759,000
-1.2%
375,0000.0%0.03%
-3.3%
Q3 2021$1,781,000
+163.9%
375,0000.0%0.03%
+150.0%
Q2 2021$675,000
+50.0%
375,000
-10.8%
0.01%
+20.0%
Q1 2021$450,000420,5360.01%
Other shareholders
BRIACELL THERAPEUTICS CORP shareholders Q1 2023
NameSharesValueWeighting ↓
Privium Fund Management B.V. 122,084$361,3690.12%
K.J. Harrison & Partners Inc 170,750$505,4200.10%
Redmond Asset Management, LLC 150,000$426,0000.07%
ARMISTICE CAPITAL, LLC 375,001$1,110,0000.02%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of BRIACELL THERAPEUTICS CORP shareholders